Key result
Patients with Embolic Stroke of Undetermined Source (ESUS) and those with atrial fibrillation had similar rates of the primary composite endpoint at 12 months (20.9% vs 18.0%, p=0.802).
Why the study?
Stroke related to AF causes high recurrence and mortality, while ESUS involves fewer vascular risk factors but also high recurrence, prompting comparison between them.
Do risk factors, functional outcomes, and the occurrence of recurrent stroke, cardiovascular death, and myocardial infarction differ between AF stroke and ESUS patients?
Cohort (n=104)
No
Do risk factors, functional outcomes, and the occurrence of recurrent stroke, cardiovascular death, and myocardial infarction differ between AF stroke and ESUS patients?
Absolute Event Rate: 20.9% vs 18%
p-value: p=0.802
Similar 12-month outcomes in AF stroke and ESUS despite baseline differences; leaves open whether uniform secondary prevention strategies suffice.
No takes yet. Share an insight, caveat, or question.
Scavasine et al. (2021) conducted a cohort in First-ever ischemic stroke (n=104). Embolic Stroke of Undetermined Source (ESUS) vs. Stroke due to Atrial Fibrillation (AF) was evaluated on Composite of recurrent stroke, cardiovascular death, and myocardial infarction (p=0.802). Patients with Embolic Stroke of Undetermined Source (ESUS) and those with atrial fibrillation had similar rates of the primary composite endpoint at 12 months (20.9% vs 18.0%, p=0.802).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: